Literature DB >> 8726834

Role of endogenous platelet-activating factor in the regulation of pancreatic blood flow during caerulein stimulation.

M Ogura1, Y Kubota, K Inoue.   

Abstract

The role of endogenous platelet-activating factor (PAF) in the control of pancreatic blood flow during caerulein stimulation was investigated. Pancreatic blood flow in anesthetized rats was measured continuously by laser Doppler flowmetry for 2 h during the intravenous infusion of caerulein (0.25 micrograms/kg per h). Pancreatic blood flow showed a gradual, consistent, and significant increase, reaching 114.2 +/- 2.3% of the basal value after 120 min. Changes in pancreatic blood flow induced by caerulein were completely inhibited by a cholecystokinin (CCK) antagonist (loxiglumide, 5 mg/ kg per h, i.v.) and by a specific PAF antagonist (CV-6209, 1 mg/kg, i.v.-bolus). Systemic blood pressure remained stable in all groups. These results suggest an important role of endogenously yielded PAF in regulating pancreatic blood flow during caerulein stimulation to the pancreas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726834     DOI: 10.1007/BF02355032

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  15 in total

1.  Studies on intracellular transport of secretory proteins in the rat exocrine pancreas. IV. Stimulation by in vivo infusion of caerulein.

Authors:  W Bieger; A Martin-Achard; M Bassler; H F Kern
Journal:  Cell Tissue Res       Date:  1976-01-28       Impact factor: 5.249

2.  Synthesis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in exocrine glands and its control by secretagogues.

Authors:  H D Söling; W Fest
Journal:  J Biol Chem       Date:  1986-10-25       Impact factor: 5.157

3.  Measurement of pancreas parenchyma perfusion by laser-Doppler flowmetry.

Authors:  J Norstein; B Lien; C Hall; K Kvernebo; L Mørkrid; O Søreide; I B Brekke; A Flatmark
Journal:  Transplant Proc       Date:  1990-04       Impact factor: 1.066

4.  Comparison of blood flow measurements by hydrogen gas clearance and laser Doppler flowmetry in the rat duodenum.

Authors:  F W Leung
Journal:  Scand J Gastroenterol       Date:  1990-05       Impact factor: 2.423

5.  Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine.

Authors:  C V Jackson; W A Schumacher; S L Kunkel; E M Driscoll; B R Lucchesi
Journal:  Circ Res       Date:  1986-02       Impact factor: 17.367

6.  CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.

Authors:  Z Terashita; Y Imura; M Takatani; S Tsushima; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

7.  The effect of secretin on pancreatic blood flow in the awake and anesthetized dog.

Authors:  R S Chung; S Safaie-Shirazi
Journal:  Proc Soc Exp Biol Med       Date:  1983-09

8.  Effect of secretin and caerulein in canine pancreas: relation to prostaglandins.

Authors:  T Homma; K U Malik
Journal:  Am J Physiol       Date:  1983-06

9.  Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue.

Authors:  M Lampel; H F Kern
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-03-11

10.  Acetylcholine-like effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine ('platelet-activating factor') and its analogues in exocrine secretory glands.

Authors:  H D Söling; H Eibl; W Fest
Journal:  Eur J Biochem       Date:  1984-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.